Delivery Order SPE2DB22D2211-SPE2DB25FSCMG
- Not listed
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.18 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 mL vials (5 mL quantity). The award is firm fixed price with no set-aside designation, reflecting a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine HCL 50ML in quantities of 25 units, with a contract value of $1,360.90. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency Troop Support Medical awarded a $103,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20ml vials of 2% xylocaine. The prime contractor will deliver the medical supplies to its facility in Conshohocken, Pennsylvania under a one day period of performance from July 31, 2023 through August 1, 2023. The award was made using the agency's Indefinite Delivery Vehicle contracts, which provide medical and pharmaceutical products to support the...
- The Defense Logistics Agency awarded a $244,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50ml vials of 1% xylocaine. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,518,688 units of the anesthetic medication Xylocaine-MPF 2% 100 mg/5 mL. The $2,623.84 contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,536.32. The order is for the supply of XYLOCAINE-MPF 2% VIAL 2ML, a local anesthetic medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCMGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply agreement extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal pharmaceutical distribution capabilities and established relationship with the DLA Medical Supply Chain position the company as a critical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/8/25 |